Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alumis Inc | 0 | 5,584,887 | +5,584,887 | $0 | $74.28M | 47.43% | +$74.28M |
| Hims & Hers Health, Inc.CL A(HIMS) | 3,326,783 | 1,759,314 | -1,567,469 | $51.47M | $35.52M | 22.68% | -$15.94M |
| CG Oncology, Inc.(CGON) | 692,550 | 692,550 | 0 | $30.40M | $21.86M | 13.96% | -$8.54M |
| Disc Medicine, Inc.(IRON) | 243,513 | 299,069 | +55,556 | $15.16M | $13.48M | 8.61% | -$1.68M |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 657,905 | +657,905 | $0 | $11.47M | 7.33% | +$11.47M |
| 23andMe Holding Co.CL A | 232,200 | 0 | -232,200 | $123.5K | $0 | — | -$123.5K |
| Kinnate Biopharma Inc. | 3,525,957 | 0 | -3,525,957 | $9.38M | $0 | — | -$9.38M |